GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AprilBio Co Ltd (XKRX:397030) » Definitions » EV-to-EBITDA

AprilBio Co (XKRX:397030) EV-to-EBITDA : -19.00 (As of Jun. 11, 2024)


View and export this data going back to 2022. Start your Free Trial

What is AprilBio Co EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, AprilBio Co's enterprise value is ₩262,203.00 Mil. AprilBio Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was ₩-13,797.36 Mil. Therefore, AprilBio Co's EV-to-EBITDA for today is -19.00.

The historical rank and industry rank for AprilBio Co's EV-to-EBITDA or its related term are showing as below:

XKRX:397030' s EV-to-EBITDA Range Over the Past 10 Years
Min: -25.64   Med: -14.66   Max: 11.87
Current: -19.01

During the past 6 years, the highest EV-to-EBITDA of AprilBio Co was 11.87. The lowest was -25.64. And the median was -14.66.

XKRX:397030's EV-to-EBITDA is ranked worse than
100% of 451 companies
in the Biotechnology industry
Industry Median: 9.01 vs XKRX:397030: -19.01

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-11), AprilBio Co's stock price is ₩14680.00. AprilBio Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ₩-637.500. Therefore, AprilBio Co's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


AprilBio Co EV-to-EBITDA Historical Data

The historical data trend for AprilBio Co's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AprilBio Co EV-to-EBITDA Chart

AprilBio Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial - - - -14.02 -24.42

AprilBio Co Quarterly Data
Mar21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -21.02 -14.24 -14.96 -24.42 -21.65

Competitive Comparison of AprilBio Co's EV-to-EBITDA

For the Biotechnology subindustry, AprilBio Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AprilBio Co's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, AprilBio Co's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where AprilBio Co's EV-to-EBITDA falls into.



AprilBio Co EV-to-EBITDA Calculation

AprilBio Co's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=262202.999/-13797.356
=-19.00

AprilBio Co's current Enterprise Value is ₩262,203.00 Mil.
AprilBio Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-13,797.36 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


AprilBio Co  (XKRX:397030) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

AprilBio Co's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=14680.00/-637.500
=At Loss

AprilBio Co's share price for today is ₩14680.00.
AprilBio Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-637.500.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


AprilBio Co EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of AprilBio Co's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


AprilBio Co (XKRX:397030) Business Description

Traded in Other Exchanges
N/A
Address
Gangwon University 1, Room 602, Building B, Medical and Bioscience College, Gangwon-daehak-gil (Hyoja-dong), Chuncheon-si, Gangwon-do, KOR
AprilBio Co Ltd is a bio company is developing innovative biologis. It owns long acting protein medicine platform technology utilizing human FAB antobody parts that makes unusual combination to serum akbumin and EX 12 helper phase antibody library technology.

AprilBio Co (XKRX:397030) Headlines

No Headlines